Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1994-06-10
1998-08-04
Ulm, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
424 854, 435 6951, 435 711, 4352523, 4353201, 514 2, 514 12, C07K 1456, C12N 1521
Patent
active
057895511
ABSTRACT:
A new class of polypeptides is disclosed, along with a method for identifying and producing such polypeptides, having the characteristic of being unique to diseased states, particularly tumors and blood-borne malignancies. These new polypeptides are active and will be useful for therapeutic purposes.
REFERENCES:
patent: 3699222 (1972-10-01), Isaacs et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4695623 (1987-09-01), Stabinsky
patent: 4801685 (1989-01-01), Goeddel et al.
patent: 5008182 (1991-04-01), Sninsky et al.
patent: 5175383 (1992-12-01), Leder et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5175385 (1992-12-01), Wagner et al.
patent: 5372808 (1994-12-01), Blatt et al.
Mizoguchi et al., (1985) DNA, vol. 4, No. 3, pp. 221-232.
Wang et al. (1994) J. Interferon Res. 14:41-6.
Emanuel et al. (1993) J. Biol. Chem. 268:12565-9.
Grander et al. (1992) Blood 79:2076-83.
Zoon et al. (1992) J. Biol. Chem. 267, No.21:15210-6.
Desai et al. (1992) J. Interferon Res. 12:s138.
Hosoi et al. (1992) International Society for Study of the Liver (Brighton, UK):113.
Antonelli et al. (1991) J. Infectious Dis. 163:882-5.
Colamonici et al. (1991) J. Interferon Res. 11:s54.
Diaz et al. (1991) J. Interferon Res. 11:s85.
Adolf et al. (1991) Biochem. 276:511-8.
Moormeier et al. (1989) Leukemia and Lymphoma 1:43-5.
Freund et al. (1989) British J. Haematology 72:350-6.
Steis et al. (1988) New Eng. J. Med. 318:1409-13.
Hotta et al. (1988) J. Interferon Res. 8:51-60.
Itri et al. (1987) Cancer 59:668-74.
Von Wussow et al. (1987) J. Interferon Res. 7:680.
Pestka et al. (1987) Ann. Rev. Biochem. 56:727-77.
Pestka, S. (1986) Methods in Enzymology 119:3-23.
Hotta et al. (1986) Methods in Enzymology 119:481-5.
Foon et al. (1986) American J. Med. 80:351-6.
Huber et al. (1985) Oncology 42, suppl.1:7-9.
Henco et al. (1985) J. Mol. Biol. 185:227-60.
Quesada et al. (1985) J. Clinical Oncology 3:1522-8.
Langer et al. (1984) J. Investigative Dermatology 83:128s-36s.
Pestka, S.(1983) Arch. Biochem. Biophys. 221:1-37.
Rehberg et al. (1982) J. Biol. Chem. 257:11497-502.
Hobbs et al. (1982) J. Biol. Chem. 257:4071-6.
Pestka et al. (1981) Methods in Enzymology (S. Pestka,ed.) 78:3-14.
Staehelin et al. (1981) J. Biol. Chem. 256:9750-4.
Rubinstein et al. (1981) Arch. Biochem. Biophys. 210:307-18.
Streuli et al. (1980) Science 209:1343-7.
Goeddel et al. (1980) Nature 287:411-6.
Koeffler et al. (1978) Science 200:1153-4.
Mertz Prema
Pestka Biomedical Laboratories, Inc.
Ulm John
LandOfFree
Human leukocyte interferon Hu-IFN-.alpha.001 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human leukocyte interferon Hu-IFN-.alpha.001, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human leukocyte interferon Hu-IFN-.alpha.001 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178383